The Value of Headache-Specific Recommendations During COVID-19.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors.Journal of general internal medicine · 2021
   Review
2. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study.The journal of headache and pain · 2021
   Article
3. Social Distancing in Chronic Migraine during the COVID-19 Outbreak: Results from a Multicenter Observational Study.Nutrients · 2021
   Observational
4. Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway.The journal of headache and pain · 2020
   Article

Corrections and comments

• Comment on
  Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.2020

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as